Hansa Biopharma half year report 2023 (2) : vimarsana.com

LUND, Sweden, July 20, 2023 /PRNewswire/ -- Hansa Biopharma, the pioneer in immunomodulatory enzyme...

Related Keywords

Berlin , Germany , Belgium , Netherlands , United Kingdom , France , Finland , United States , Sweden , Australia , Australian , American , Donato Spota , Matthew Shaulis , Adrian Schreiber , Philipp Enghard , Stephanie Kenney , Prnewswire Hansa Biopharma , Klaus Sindahl , Hansa Biopharma , Acceptable Mismatch Program , American Society Of Gene , Australian Therapeutic Goods Administration , Acceptable Mismatch , American Society , Cell Therapy Conference , Duchenne Muscular , Lead Nicer , Crigler Najjar Phase , Report January , Thursday July , Securities Markets , Investor Relationsm , Corporate Affairsm ,